• Nenhum resultado encontrado

acute promyelocytic leukemia

Arterial thrombosis in acute promyelocytic leukemia.

Arterial thrombosis in acute promyelocytic leukemia.

... promyeloclocytic leukemia can present coagulopathies which are frequently very serious due to hemorrhagic ...with acute arterial insufficiency was ...showed acute promyelocytic leukemia ...

2

Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.

Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.

... novo acute myeloid leukemia, patients with acute promyelocytic leukemia had lower platelet counts and fibrinogen levels, significantly prolonged prothrombin time and elevated D-dimers ...

11

Acute promyelocytic leukemia: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques

Acute promyelocytic leukemia: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques

... Acute promyelocytic leukemia (AML M3) is a well-defined subtype of leukemia with specific and peculiar characteristics. Immediate identification of t(15;17) or the PML/RARA gene rearrangement ...

9

Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines

Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines

... et al. Definition of relapse risk and role of nonanthracy- cline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. ...

2

Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center

Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center

... diagnosed acute promyelocytic leukemia: a pilot study on 26 ...in acute promyelocytic leu- kemia: Impact of leukocytosis, low -dose chemotherapy, PM N/RAR-α isoform, and CD13 expression ...

8

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.

... Acute promyelocytic leukemia (APL) was a specific type of acute myeloid leukemia (AML) associated with the fusion of promyelocytic (PML) gene with the retinoic acid receptorα ...

10

Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia

Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia

... for acute promyelocytic leukemia (APL) has markedly ...the promyelocytic leu- kemia/retinoic acid receptor-alpha (PML/RARα) isoforms bcr 2 and bcr 3 is higher in children than in ...

11

Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associacao Medica Brasileira - 2013

Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associacao Medica Brasileira - 2013

... Mortality rate of 16.34% was observed during the induction treatment with deaths due to infection, pulmonary or cerebral hemorrhage and Differentiation syndrome; 3.8% of the deaths during consolidation treatment were by ...

22

J. Braz. Chem. Soc.  vol.26 número4

J. Braz. Chem. Soc. vol.26 número4

... human acute promyelocytic leukemia cells (NB4), human lung adenocarcinoma (A549), human neuroblastoma (SHSY5Y), human prostate (PC3), and human breast adenocarcinoma ...

5

Rev. Bras. Hematol. Hemoter.  vol.38 número4

Rev. Bras. Hematol. Hemoter. vol.38 número4

... 16. Common Terminology Criteria for Adverse Events v4.03 (CTCAE). Bethesda, MD: National Cancer Institute; 2010, June [cited 03.06.15]. Available from: http://evs.nci.nih.gov/ftp1/ CTCAE/CTCAE 4.03 2010-06-14 ...

6

Rev. Bras. Hematol. Hemoter.  vol.26 número3

Rev. Bras. Hematol. Hemoter. vol.26 número3

... that leukemia cells have to bind to FN and/or Coll IV associated or not with ...cells: acute promyelocytic leukemia cells (HL-60), histiocytic lymphoma derived cells (U937), chronic myelocytic ...

6

J. Bras. Patol. Med. Lab.  vol.44 número1

J. Bras. Patol. Med. Lab. vol.44 número1

... Hybrid gene PML-RARα is the molecular target found in most cases of acute promyelocytic leukemia (APL) and has been used for diagnosis and minimal residual disease studies. The standard molecular ...

4

Rev. Bras. Hematol. Hemoter.  vol.33 número6

Rev. Bras. Hematol. Hemoter. vol.33 número6

... of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA ...

3

Do paradigma molecular ao impacto no prognóstico: uma visão da leucemia promielocítica aguda.

Do paradigma molecular ao impacto no prognóstico: uma visão da leucemia promielocítica aguda.

... Acute promyelocytic leukemia (APL) is a model of clinical applicability of the knowledge of molecular ...other acute myeloid leukemia due to a higher incidence in young adults and in ...

8

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... 4. Jácomo RH, Melo RA, Souto FR, de Mattos ER, de Oliveira CT, Fagundes EM, et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and ...

6

FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

... T-cell leukemia cell lines Jurkat, BE13 and MOLT-4 were obtained from the German Resource Center for Biological Material, DSMZ (Braunschweig, Germany) and previ- ously characterized on a molecular level ...

10

Acute leukemias in Piauí: comparison with features observed in other regions of Brazil

Acute leukemias in Piauí: comparison with features observed in other regions of Brazil

... of acute leukemias (children and adults, ALL and AML) observed at a large regional hospital in Teresina, PI, northern Brazil, which repre- sents the only cancer center for a region of about 3 million ...

7

Yuni Wu, Youhua Xu, Yali Shen, Cuicui Wang, Gaili Guo and Tiantian Hu

Yuni Wu, Youhua Xu, Yali Shen, Cuicui Wang, Gaili Guo and Tiantian Hu

... associated with the induction of apoptosis, and thus, dif- ferentiation-inducing therapy may be useful in combination with intensive chemotherapy to increase the susceptibility of leukemia blast cells to ...

11

Age Difference in Immunophenotype of Acute Leukemia

Age Difference in Immunophenotype of Acute Leukemia

... relatively low percentage of such leukemia in comparison with the other age groups due to the high frequency of T-cell ALL. Regarding the karyotype, the incidence of Ph significantly rose with increasing patient ...

7

J. Braz. Chem. Soc.  vol.27 número12

J. Braz. Chem. Soc. vol.27 número12

... human promyelocytic leukemia (HL-60), ovarian carcinoma (OVCAR-8), glioma (SF-295) human cancer cell lines, and the antimicrobial activity was evaluated against Candida parapsilosis, ...

11

Show all 3378 documents...

temas relacionados